China News Agency, Berlin, October 2 (Reporter Peng Dawei) The German Federal Agency for Disease Control and Prevention announced on the 2nd that the number of newly diagnosed new coronavirus infections was 2,673, which once again hit a new high since April this year.

On the same day, 339 new cases were confirmed in the capital Berlin, the highest single-day increase in the city since the outbreak.

The Berlin health department announced that the "7-day average number of new additions" used to monitor the development of the epidemic had lit a "red light."

　　The German Federal Agency for Disease Control and Prevention Robert Koch Institute announced on the 2nd that the number of newly diagnosed cases in 24 hours was 2,673.

Since the peak of the epidemic in Germany at the end of March and early April, the number of new cases in a single day has dropped significantly, but there has been a rebound since the end of July and it has continued to this day.

　　In addition, according to the real-time epidemic data released by the German mainstream media "Times Online", as of 15:00 local time on the 2nd, a total of 2,96065 people were diagnosed, 259,494 people were cured, and 9,660 people died in Germany.

　　As the most populous city in Germany, the capital Berlin has recently rebounded from the epidemic.

The Berlin Ministry of Health announced that there were 339 new cases in a single day, the highest since the outbreak of the new crown in Germany at the beginning of this year.

　　Among them, among the three “traffic lights” of the new crown monitoring and early warning system established by the city of Berlin, the “average number of new additions per 100,000 people in 7 days” rose to 34.5 on the same day, and the red light has been lit-the current indicator throughout Germany 15.

The other two indicators, namely the number of intensive care beds and the R0 value of the basic infection number, are still in the green light state.

　　Since the outbreak, 15,370 people have been diagnosed in Berlin, of which 13,060 have been cured, and another 231 have died.

　　As winter approaches, Germany is speeding up the vaccine development process.

The German Federal Vaccine Regulatory Agency Paul Ehrlich Institute announced the approval of a new vaccine clinical trial on the same day.

This vaccine was developed by the German Institute of Infection Research (DZIF), and participating institutions include the University of Munich, the University of Marburg and the University Hospital of Hamburg.

Starting in mid-October, 30 healthy volunteers between the ages of 18-55 will participate in clinical testing of the vaccine.

(Finish)